Table 1.
Demographics of the Study Cohort.
| Characteristics | Value, n = 9 |
|---|---|
| Male (%) | 9 (100.0) |
| Median child age at participation (range) | 13.4 (3.6-16.7) |
| Diagnosis (%)a | |
| Leukemia/Lymphoma | 1 (11.1) |
| Solid tumor | 6 (66.7) |
| Brain tumor | 2 (22.2) |
| Median months since diagnosis (IQR) | 3.3 (2.0, 4.7) |
| Relapsed (%) | 1 (11.1) |
| Extent of disease (%) | |
| Nonmetastatic | 4 (44.4) |
| Metastatic | 5 (55.6) |
| Median baseline hemoglobin (g/L) (IQR) | 117.0 (97.0, 125.0) |
| Median baseline Symptom Distress Scale (IQR) | 3.0 (2.0, 4.0) |
Abbreviation: IQR, interquartile range.
a
Diagnoses included Hodgkin’s lymphoma (n = 1), medulloblastoma (n = 2), hepatoblastoma (n = 1), osteosarcoma (n = 2), rhabdomyosarcoma (n = 1), and Ewing sarcoma (n = 2).